PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics disclosed inducement equity grants approved Oct. 28, 2026 for 13 new employees under Nasdaq Listing Rule 5635(c)(4). The grants cover options to purchase an aggregate of 9.620 shares (a typo in the release, likely 9,620) and 11,535 RSUs, with a $63.02 option exercise price and four-year vesting.
Key figures
- Vesting
- 4-year vesting for options and RSUs
- Rsus granted
- 11535
- New employees
- 13
- Option exercise price
- $63.02
- Options granted shares
- 9620
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.